Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment

Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment

Detalles Bibliográficos
Main Authors: Robinson, PC, Richards, D, Tanner, HL, Feldmann, M
Formato: Journal article
Idioma:English
Publicado: Elsevier 2020

Títulos similares